Shows 90 % overall efficacy and 100 % protection against moderate and severe disease in Phase 3 study, according to manufacturer
Novavax's COVID-19 Vaccine Candidate
Most Accessed Articles: May 2021
Highlights from Chemistry Europe, ACES, and GDCh journals
Lonza and Moderna Collaborate for Drug Substance Manufacturing
New mRNA production line in the Netherlands will support the manufacture of up to 300 million additional COVID-19 vaccine doses per year
Methane Emissions from Oil and Gas Production Mapped
Airborne imaging spectrometry used to study methane leaks in the Permian Basin in the southwestern U.S.
Arkema Acquires Agiplast
Agiplast has distinctive know-how in mechanical recycling technologies
Your Molecule Story
Share a molecule and why it is special to you and have the chance to win a book
Interdisciplinary Cultured Meat Research
Merck collaborates with TU Darmstadt and Tufts University on bioreactor designs for cultured meat production
Merck Accelerates Scale Up of Lipids for mRNA Covid-19 Vaccines
New, high-purity synthetic cholesterol product launched nine months ahead of schedule
BASF and RWE Cooperate on New Technologies for Climate Protection
Offshore wind farm with a capacity of 2 GW to supply chemical site with green electricity and enable CO2-free production of hydrogen
Reducing CO2 Emissions of Gasoline Cars
Neste tests renewable drop-in gasoline in Sweden for possible commercialization